BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6321126)

  • 1. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
    [No Abstract]   [Full Text] [Related]  

  • 2. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
    Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
    Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabilone and other antiemetics for cancer patients.
    Med Lett Drugs Ther; 1988 Jan; 30(756):2-4. PubMed ID: 2826977
    [No Abstract]   [Full Text] [Related]  

  • 4. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
    Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
    N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
    Chan HS; Correia JA; MacLeod SM
    Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic marijuana for nausea and vomiting due to cancer chemotherapy.
    Med Lett Drugs Ther; 1985 Nov; 27(701):97-8. PubMed ID: 2999571
    [No Abstract]   [Full Text] [Related]  

  • 7. Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis.
    Niamatali C; Fallon SD; Egan EL
    Ir Med J; 1984 Sep; 77(9):276-7. PubMed ID: 6090342
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacotherapy of emesis caused by cytostatic agents].
    Baggerman C
    Ned Tijdschr Geneeskd; 1982 May; 126(18):803-7. PubMed ID: 6283396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
    George M; Pejovic MH; Thuaire M; Kramar A; Wolff JP
    Biomed Pharmacother; 1983; 37(1):24-7. PubMed ID: 6311306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.
    Bruera ED; Roca E; Cedaro L; Chacón R; Estévez R
    Cancer Treat Rep; 1983 Apr; 67(4):381-3. PubMed ID: 6342770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug treatment of nausea and vomiting caused by cancer chemotherapy].
    Havsteen H; Kjaer M
    Ugeskr Laeger; 1989 Feb; 151(7):430-4. PubMed ID: 2645736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
    Steele N; Gralla RJ; Braun DW; Young CW
    Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of cipropride in the treatment of digestive disorders induced by anticancer chemotherapy. Double-blind study using metoclopramide].
    Cristau P; Laverdant C; Coquelin JP; Narbonne G
    Med Chir Dig; 1981; 10(4):359-64. PubMed ID: 7029166
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
    Pruitt BT; Justice RL; Periman P
    Tex Med; 1985 Jul; 81(7):44-5. PubMed ID: 3898458
    [No Abstract]   [Full Text] [Related]  

  • 15. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
    Stuart-Harris RC; Mooney CA; Smith IE
    Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children.
    Van Eygen M; Dhondt F; Heck E; Ameryckx L; Van Ravensteyn H
    Postgrad Med J; 1979; 55 Suppl 1():36-9. PubMed ID: 382153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nabilone: a potent antiemetic cannabinol with minimal euphoria.
    Herman TS; Jones SE; Dean J; Leigh S; Dorr R; Moon TE; Salmon SE
    Biomedicine; 1977 Dec; 27(9-10):331-4. PubMed ID: 606307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chemotherapy-induced nausea and emesis.
    Maule WF; Perry MC
    Am Fam Physician; 1983 Jan; 27(1):226-34. PubMed ID: 6130699
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiemetics for patients treated with antitumor chemotherapy.
    Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
    Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nabilone (Cesamet) for chemotherapy-induced nausea and vomiting.
    Med Lett Drugs Ther; 2006 Dec; 48(1249/1250):103-4. PubMed ID: 17149361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.